27602 Long-term efficacy and safety of once-daily topical efinaconazole 10% topical solution (Jublia) for dermatophyte toenail onychomycosis: An interim analysis

Abstract

Introduction: Efinaconazole 10% topical solution (efinaconazole) labeling for onychomycosis describes 12-month phase III trials; the slow growth of onychomycotic nails suggests a longer treatment period may increase efficacy. We present here for the first time an interim evaluation of once-daily efinaconazole over 24 months.